Combined mismatch repair and POLE/POLD1 defects explain unresolved suspected Lynch syndrome cancers
2015 · European Journal of Human Genetics · 125 citations
https://doi.org/10.1038/ejhg.2015.252
A
Anne M.L. Jansen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
114
Papers
665
Citations
10
h-index
10
i10-index
Anne M.L. Jansen is an academic researcher from Utrecht University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Cancer Genomics and Diagnostics & Lung Cancer Treatments and Mutations. The author has an h-index of 10, co-authored 97 publications.
ORCID: 0000-0002-8793-0563Papers by this author
worksTrastuzumab and pertuzumab combination therapy for advanced pre-treated HER2 exon 20-mutated non-small cell lung cancer
2022 · European Journal of Cancer · 24 citations
https://doi.org/10.1016/j.ejca.2022.05.009
Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours
2023 · BMC Cancer · 12 citations
https://doi.org/10.1186/s12885-023-10663-2
Characterization of discordance between mismatch repair deficiency and microsatellite instability testing may prevent inappropriate treatment with immunotherapy
2024 · The Journal of Pathology · 5 citations
https://doi.org/10.1002/path.6279
The Innate Immune Landscape of dMMR/MSI Cancers Predicts the Outcome of Nivolumab Treatment: Results from the Drug Rediscovery Protocol
2024 · Clinical Cancer Research · 4 citations
https://doi.org/10.1158/1078-0432.ccr-24-0480
The pathway alteration load is a pan-cancer determinant of outcome of targeted therapies: results from the Drug Rediscovery Protocol (DRUP)
2025 · ESMO Open · 4 citations
https://doi.org/10.1016/j.esmoop.2024.104112
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat